ILK1 Antibody

About the Target

ILK1 is a target of interest in many antibody-based workflows. Integrin-linked kinases (ILKs) serve as mediators linking integrins and growth factors to downstream signaling pathways crucial for cell survival, cell cycle regulation, cell-cell adhesion, and cell motility. Functioning as a scaffold, ILK facilitates the connection between the extracellular matrix (ECM) and growth factor receptors with the actin cytoskeleton by interacting with integrin, PINCH (which connects ILK to receptor tyrosine kinases via Nck2), CH-ILKBP, and affixin. Depending on the literature source, ILK1 may also be discussed as ILK and Integrin linked ILK.

Reported cellular context includes cell junction, cell membrane, cell projection, and cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following ILK1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

ILK1 is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cell membrane, and cell projection, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell junction, cell membrane, and cell projection across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ILK1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ILK1 reflect biology rather than handling. When interpreting ILK1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep ILK1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.